Company Description

GondolaBio, a spin-off from BridgeBio Pharma, is a clinical-stage biopharmaceutical company focused on developing novel medicines for patients living with genetic diseases. GondolaBio aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, modalities, and stages ranging from early discovery to clinical development.